Brief: Exact Therapeutics Starts Collaboration With Agenus
08/10/2024 12:02
Oct 8 (Reuters) - Exact Therapeutics AS EXTX.OL :
* INITIATES PRECLINICAL IMMUNOTHERAPY COLLABORATION WITH
AGENUS
INC.
Source text for Eikon: ID:nObi5YbgHa
Further company coverage: EXTX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Exact Therapeutics AS
See all newsBrief: EXACT Therapeutics AS Gets Positive Safety Review For 60 Μl/Kg Dose In Phase 2 ENACT Trial
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial